10 Best Dividend Monarchs to Invest in Now

8. Becton, Dickinson and Company (NYSE:BDX)

Number of Hedge Fund Holders: 56

Becton, Dickinson and Company (NYSE:BDX) is an American medical device company, headquartered in New Jersey. In addition to medical equipment, the company also specializes in instrument systems and reagents. In its fiscal Q1 2025 earnings report, the company mentioned that it is continuing its transformation under the BD 2025 strategy, with the planned separation of Biosciences and Diagnostic Solutions building on the progress already made. According to the company, the move aims to create substantial value for both the newly streamlined BD and the separated Biosciences and Diagnostic Solutions businesses, allowing each to concentrate more fully on driving growth, advancing innovation, and achieving operational excellence within their specific markets.

Becton, Dickinson and Company (NYSE:BDX) reported revenue of $5.1 billion in Q1 2025, up nearly 10% from the same period last year. The revenue also beat analysts’ estimates by $59.6 million. The US market represented over $3 billion of the total revenue, which also showed a 12% growth on a YoY basis. BD Medical remained the winner among the other segments, generating $2.6 billion in revenues, up over 17% from the prior-year period.

Becton, Dickinson and Company (NYSE:BDX) ended the quarter with $711 million available in cash and cash equivalents. It also generated $693 million in operating cash flow. This strong cash position has enabled the company to maintain its dividend policy over all these years. BDX has been rewarding shareholders with growing dividends for the past 53 years, which makes it one of the best Dividend Monarchs on our list. Currently, it offers a quarterly dividend of $1.04 per share and has a dividend yield of 2.05%, as of April 15.